Who are we?

Supercharged is not just another news outlet. We’re a platform on a mission to offer personalized and ad-free news directly to you. Discover more of Supercharged.

Apple Watch blood oxygen feature faces uncertain future

Apple is preparing to disable the blood oxygen feature on its latest Watch models, the Series 9 and Ultra 2 according to a new report by Bloomberg in a move to potentially avoid a renewed import ban in the United States. This drastic measure follows an ongoing legal battle with Masimo, a medical technology company claiming infringement on its pulse oximetry patents.

The saga began in October 2023 when the U.S. International Trade Commission (ITC) ruled in favor of Masimo, deeming Apple’s blood oxygen measurement technology in violation of their intellectual property rights. This led to a temporary halt in smartwatch sales, followed by a court-ordered resumption while Apple pursued an appeal.

Faced with the possibility of another sales suspension, Apple’s solution comes in the form of a software modification that essentially removes the blood oxygen feature from the implicated Apple Watch models. According to U.S. Customs and Border Protection, this adjustment falls outside the scope of the import ban, potentially allowing continued sales.

However, this step isn’t without its consequences. Removing the blood oxygen feature, a highly promoted and well-received functionality, could negatively impact customer demand. Analysts like Tamlin Bason of Bloomberg Intelligence have highlighted this potential downside, noting that “Apple may have paid a steep price to get around the ban.”

While avoiding the immediate disruption of a reimposed ban is beneficial, it doesn’t fully resolve the underlying issue. Apple continues to pursue a broader stay on the ITC’s ruling through the U.S. Court of Appeals for the Federal Circuit, with a decision expected as early as this week. Additionally, the company’s engineers are reportedly working on a software update that could restore the blood oxygen feature while complying with the court’s order by altering the sensor’s algorithms.

The situation remains fluid and complex, with both sides presenting strong arguments. Masimo emphasizes the importance of intellectual property protection and compliance with regulations, while Apple seeks to defend its technology and maintain customer trust. Ultimately, the court’s rulings and Apple’s ongoing efforts will determine the fate of the blood oxygen feature on future Apple Watch models.

This situation serves as a reminder of the intricate interplay between innovation, intellectual property, and legal frameworks in the tech industry. It’s a story with implications not just for Apple and Masimo, but for the broader landscape of wearable technology and its potential for health monitoring and well-being.

TOPICS: ,
Share this Article
note icon

Did you know?

Easily add Supercharged to your Home Screen and stay informed on the go! Get instant updates and breaking news stories via push notifications directly on your iPhone and Apple Watch. Just tap the share icon, then "Add to Home Screen," and be the first to know.

Have a tip for our newsroom? Securely reach out to us and tell us what you know. Your insight and information are invaluable to the work we do. 

Editor's Pick

Abdul Raouf Al Sbeei

Abdul Raouf Al Sbeei

Abdul Raouf is a reporter in the Apple Newsroom, where he translates news into insightful and relatable stories. Abdul believes words hold magic and have power often ignored. You can find him between tweets or book pages.

Read More

Who are we?

Supercharged is not just another news outlet. We’re a platform on a mission to offer personalized and ad-free news directly to you. Discover more of Supercharged.

Apple Watch blood oxygen feature faces uncertain future

Apple is preparing to disable the blood oxygen feature on its latest Watch models, the Series 9 and Ultra 2 according to a new report by Bloomberg in a move to potentially avoid a renewed import ban in the United States. This drastic measure follows an ongoing legal battle with Masimo, a medical technology company claiming infringement on its pulse oximetry patents.

The saga began in October 2023 when the U.S. International Trade Commission (ITC) ruled in favor of Masimo, deeming Apple’s blood oxygen measurement technology in violation of their intellectual property rights. This led to a temporary halt in smartwatch sales, followed by a court-ordered resumption while Apple pursued an appeal.

Faced with the possibility of another sales suspension, Apple’s solution comes in the form of a software modification that essentially removes the blood oxygen feature from the implicated Apple Watch models. According to U.S. Customs and Border Protection, this adjustment falls outside the scope of the import ban, potentially allowing continued sales.

However, this step isn’t without its consequences. Removing the blood oxygen feature, a highly promoted and well-received functionality, could negatively impact customer demand. Analysts like Tamlin Bason of Bloomberg Intelligence have highlighted this potential downside, noting that “Apple may have paid a steep price to get around the ban.”

While avoiding the immediate disruption of a reimposed ban is beneficial, it doesn’t fully resolve the underlying issue. Apple continues to pursue a broader stay on the ITC’s ruling through the U.S. Court of Appeals for the Federal Circuit, with a decision expected as early as this week. Additionally, the company’s engineers are reportedly working on a software update that could restore the blood oxygen feature while complying with the court’s order by altering the sensor’s algorithms.

The situation remains fluid and complex, with both sides presenting strong arguments. Masimo emphasizes the importance of intellectual property protection and compliance with regulations, while Apple seeks to defend its technology and maintain customer trust. Ultimately, the court’s rulings and Apple’s ongoing efforts will determine the fate of the blood oxygen feature on future Apple Watch models.

This situation serves as a reminder of the intricate interplay between innovation, intellectual property, and legal frameworks in the tech industry. It’s a story with implications not just for Apple and Masimo, but for the broader landscape of wearable technology and its potential for health monitoring and well-being.

TOPICS: ,
Share this Article
note icon

Did you know?

Easily add Supercharged to your Home Screen and stay informed on the go! Get instant updates and breaking news stories via push notifications directly on your iPhone and Apple Watch. Just tap the share icon, then "Add to Home Screen," and be the first to know.

Have a tip for our newsroom? Securely reach out to us and tell us what you know. Your insight and information are invaluable to the work we do. Click here.

Have a tip for our newsroom? Securely reach out to us and tell us what you know. Your insight and information are invaluable to the work we do. 

Editor's Pick

Abdul Raouf Al Sbeei

Abdul Raouf Al Sbeei

Abdul Raouf is a reporter in the Apple Newsroom, where he translates news into insightful and relatable stories. Abdul believes words hold magic and have power often ignored. You can find him between tweets or book pages.

Read More

Craig Federighi

Age: 54
Search

Affiliate links are a popular way for websites to make money, but they can also be annoying to readers. They can obstruct content, trick visitors, and even be scams.

Supercharged is committed to respecting your time, sanity, and convenience. That’s why we’re doing affiliate linking differently.

You Control What You See

Have you ever felt like you're bombarded with affiliate links and ads constantly? We understand how overwhelming that can be, which is why we want to give you some control with the option to expand the affiliate options that you find interesting.

We're Strict

We have a strict policy of showing you a maximum of five brands or products at once. It's simple: if we wouldn't buy it ourselves, we won't recommend it to you.

No Tracking or Creepy Cookies

For all of our affiliates, we work directly with the companies to offer discounts and deals for you. We do not use third-party affiliate managers, trackers, or platforms like Amazon, so you can be confident that you won't have to deal with tracking.

Secured By miniOrange